$ Finance & Markets

Stocks, Crypto & Economic News

Evening Update 22:42

Die Finanzmärkte reagieren volatil auf steigende Inflation, geopolitische Spannungen und bevorstehende Verhandlungen zwischen den USA und dem Iran. Während die Wall Street uneinheitlich schließt und der DAX sich erholt, belasten steigende Energiepreise und ein möglicher Förderstopp für Solaranlagen die Stimmung.

US-Konsumklima erreicht Rekordtief aufgrund von Inflation und Iran-Konflikt
Wall Street und DAX reagieren auf Inflationsdaten und Iran-Verhandlungen
Möglicher Förderstopp gefährdet Rentabilität von Mieterstromprojekten
Gericht stellt Verfahren gegen UBS in Mosambik-Affäre ein
Journalisten wollen Bitcoin-Erfinder Satoshi Nakamoto identifiziert haben

Search by Ticker

Search by Company

Active filters: $ARM ×

$ Finance & Markets

Under Armour maintains fiscal 2027 adjusted operating income outlook of $140M-$160M while cutting gross margin expansion view to 170-220 bps

Ars Pharmaceuticals targets cash flow breakeven by year-end 2027 as neffy U.S. share surpasses 5%

Under Armour warns higher costs will weigh on FY27 profit margins

Under Armour reports mixed Q2 results; updates FY2027 outlook

Guardian Pharmacy Services Non-GAAP EPS of $0.33 beats by $0.02, revenue of $371.1M beats by $5.34M

Karman outlines $755M-$760M 2026 revenue outlook as backlog reaches $1.7B

Ginkgo reaffirms 2026 cash burn guidance of $125M-$150M while outlining first pharma autonomous lab sale to Novo Nordisk

Pegasystems wins 10-year U.S. Army contract with $419M ceiling

Israel's $10B arms backlog complicates Trump's plan to end military aid

LifeMD mail-order pharmacy to ship Lilly weight-loss meds directly to patients

Zenas BioPharma GAAP EPS of -$1.65 misses by $0.41, revenue of $10M

Innate Pharma reports €96.8M in cash, outlines key 2027 pipeline milestones

NewAmsterdam Pharma GAAP EPS of -$0.14 beats by $0.30, revenue of $19.16M beats by $4.11M

Arm signals up to $2B in Arm AGI CPU revenue across fiscal 2027-2028 as Q3 revenue seen at $1.54B

Lyell Immunopharma reports Q3 results

Royalty Pharma raises 2026 portfolio receipts guidance to $3.5B-$3.55B while outlining $1.7B-plus future peak royalties

Medicus Pharma jumps as SkinJect explores $135M SPAC deal

Astellas Pharma ADR GAAP EPS of v134.47, revenue of ¥1270.86B; updates FY2027 outlook

Hydrofarm eliminates $109M in debt through recapitalization

Harmonic forecasts $545M-$555M 2026 revenue while raising full-year EPS to $0.80-$0.84

Under Armour tops most shorted consumer discretionary stock with market cap above $2B

Snap settles teen social media harm lawsuit during trial

L3Harris receives $121M in U.S. Army radio equipment orders

Bangladesh garment factories said to reopen amid wage protests